South Dakota's AG says federal rescheduling barely touches the state's medical program

South Dakota Attorney General Marty Jackley, a Republican, issued an official opinion on October 13 concluding that the federal move of state-licensed medical marijuana to Schedule III does not undercut the state's medical cannabis program. The legislature's Medical Marijuana Oversight Committee had asked for the opinion, and some lawmakers had earlier wanted to repeal the program once rescheduling was certified.

Jackley's reasoning leans on the April federal order. Under it, existing state-licensed medical manufacturers, distributors and dispensaries can keep operating in line with federal law if they register with the DEA. He also argued that Congress has not preempted state action in this area and that South Dakota's medical law does not conflict with the federal schedule, comparing it to how federal hemp legalization carried a no-preemption clause.

One useful detail: South Dakota does not currently schedule marijuana under its own law, and the opinion says any move to adopt a Schedule III classification at the state level would take the legislature or voters. Jackley listed six possible directions lawmakers could take, and said none is ruled out by current state or federal law.

The takeaway for anyone watching state-by-state exposure is that rescheduling is not automatically a trigger for repeal in the red states with medical programs. Regulators there were short on federal guidance as recently as August, so a clear written opinion from the state's top lawyer lowers the odds of an abrupt rollback. It does not settle the politics, since repeal bills can come back.